COVID-19 Enfeksiyonu Geçiren ve Geçirmeyen Sağlık Çalışanlarında İki Doz İnaktive SARS-CoV-2 Aşısı Sonrası Antikor Yanıtı: Prospektif Gözlemsel Çalışma

Özgür, Didem; Tütüncü, Emin Ediz

doi:10.5578/mb.20229904

Cited by 5 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In two studies conducted in Turkey, antibody positivity was 97.7% and 98.5% 28 days after two doses of the CoronaVac vaccine, similar to our study (17,18). In the studies carried out among healthy adults, the CoronaVac vaccine was evaluated with a short follow-up of up to 56 days and showed a better antibody response to the participants who had a COVID-19 history before vaccination (19)(20)(21)(22).…”

Section: Discussionsupporting

confidence: 85%

“…In another study conducted by health professionals in Turkey, the highest antibody levels were identified in women in the 19-30 age group after the inactive SARS-COV-2 vaccine (18).…”

Section: Discussionmentioning

confidence: 93%

“…According to recent research, the main factors that may influence vaccine response are young age, female sex, and COVID-19 history before vaccination. (17,18,22,23).…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Evaluation of Antibody Levels After Vaccination (Sinovac-CoronaVac) in Healthcare Workers

ERDOGAN

PEHLİVANOGLU

SENGÖZ

et al. 2022

J Microbil Infect Dis

View full text Add to dashboard Cite

Objectives: This study aims to evaluate the effectiveness of the inactivated SARS-COV-2 vaccine (Sinovac-CoronaVac), first administered to healthcare professionals in Turkey on January 14, 2021. Methods: Healthcare professionals without a history of COVID-19, PCR test positivity, or chronic disease were included in the study. The antibody levels for S1 RBD antigen were measured with the Siemens SARS-CoV-2 IgG (sCOVG) kit one month and six months after the two-dose CoronaVac vaccine. Results: A total of 108 health professionals, 35 women and 73 men, were included in this study. The mean age of the participants was 37.5 ± 10.7 years. A total of 103 (95.3%) individuals had positive antibody values, and five (4.6%) had negative values after the second vaccination. After the second vaccine dose, 11 (10.1%) participants were diagnosed with COVID-19. There was a significant decrease in antibody values in the sixth month compared to the first month (p

show abstract

Section: Discussionsupporting

confidence: 85%

“…In another study conducted by health professionals in Turkey, the highest antibody levels were identified in women in the 19-30 age group after the inactive SARS-COV-2 vaccine (18).…”

Section: Discussionmentioning

confidence: 93%

See 1 more Smart Citation

Evaluation of Antibody Levels After Vaccination (Sinovac-CoronaVac) in Healthcare Workers

ERDOGAN

PEHLİVANOGLU

SENGÖZ

et al. 2022

J Microbil Infect Dis

View full text Add to dashboard Cite

show abstract

“…Fourteen cohort and cross-sectional studies assessed associations between anti-S and adiposity (BMI, waist circumference) following COVID-19 vaccinations. The directionality of associations was inconsistent [ 86 ]; specifically, 7 studies showed null associations [ [87] , [88] , [89] , [90] , [91] , [92] , [93] ], 3 found positive associations [ 81 , 94 , 95 ], and 3 showed inverse associations [ [96] , [97] , [98] ]. Anti-S levels were evaluated in all studies except for one that assessed seroprevalence [ 88 ].…”

Section: Anti-s Binding Antibodiesmentioning

confidence: 99%

Bidirectionality between Cardiometabolic Diseases and COVID-19: Role of Humoral Immunity

Jackman

Glesby

et al. 2023

Advances in Nutrition

View full text Add to dashboard Cite

Antibody response three months after SARS‐CoV‐2 infection

GULTEKİN

GULTEKIN

COŞKUN

et al. 2022

Journal of Medical Virology

View full text Add to dashboard Cite

The coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. In our study, it was aimed to determine the antibody levels in the third month after the COVID-19 infection and the symptoms that continued until the third month from the onset of the infection. One hundred people who applied to Tarsus State Hospital with the suspicion of COVID-19 and were positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by realtime reverse transcriptase-polymerase chain reaction were included. We collected serum samples from individuals, who were 3 months postinfection, and tested them in anti-SARS-CoV-2 Quanti-Vac ELISA IgG kit coated with recombinant S1 antigen for testing SARS-CoV-2 antibodies. Antibody levels were found to be higher in those aged ≥55 years, nonsmokers, those with comorbidities, and those who were hospitalized. The four most common symptoms that individuals initially encounter; are weakness, muscle and joint pain, loss of taste and smell, and cough. In 3 months after COVID-19 infection, the most common four symptoms are; muscle and joint pain, insomnia, fatigue, and other problems were determined. In conclusion; more research is needed to determine threshold levels of serum antibodies that could prevent reinfection of SARS-CoV-2.

show abstract

COVID-19 Enfeksiyonu Geçiren ve Geçirmeyen Sağlık Çalışanlarında İki Doz İnaktive SARS-CoV-2 Aşısı Sonrası Antikor Yanıtı: Prospektif Gözlemsel Çalışma

Cited by 5 publications

References 0 publications

Evaluation of Antibody Levels After Vaccination (Sinovac-CoronaVac) in Healthcare Workers

Evaluation of Antibody Levels After Vaccination (Sinovac-CoronaVac) in Healthcare Workers

Bidirectionality between Cardiometabolic Diseases and COVID-19: Role of Humoral Immunity

Antibody response three months after SARS‐CoV‐2 infection

Contact Info

Product

Resources

About